Informa plc (INF.L) – What Are Brokerages Saying About This Stock?

Informa plc (LON:INF) has been assigned a consensus rating of “Buy” from the six ratings firms that are covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 12 month target price among analysts that have covered the stock in the last year is GBX 1,160.

Several analysts have issued reports on the stock. Berenberg Bank reissued a “buy” rating and issued a GBX 1,040 price objective on shares of Informa in a research note on Thursday, October 8th. Deutsche Bank Aktiengesellschaft boosted their target price on Informa from GBX 1,140 to GBX 1,290 and gave the company a “buy” rating in a research report on Friday, October 9th. JPMorgan Chase & Co. cut their target price on Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating on the stock in a research note on Thursday, July 2nd. Finally, Citigroup increased their price target on Informa from GBX 990 to GBX 1,090 and gave the stock a “buy” rating in a report on Wednesday, August 12th.

Informa Price Performance

Informa stock opened at GBX 890.80 on Wednesday. Informa has a 12-month low of GBX 719 and a 12-month high of GBX 1,000. The company has a current ratio of 0.55, a quick ratio of 1.70 and a debt-to-equity ratio of 64.99. The firm has a 50-day moving average price of GBX 892.37 and a 200-day moving average price of GBX 855.42. The firm has a market capitalization of £11.13 billion, a PE ratio of 52.09, a price-to-earnings-growth ratio of 0.75 and a beta of 0.71.

Informa (LON:INF) last issued its quarterly earnings results on Thursday, July 30th. The company reported GBX 26.70 EPS for the quarter. Informa had a net margin of 5.43% and a return on equity of 3.90%. As a group, equities research analysts forecast that Informa will post 59.32 EPS for the current year.

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.